Scientia Press

1. Biophotonic Therapy is the use of light to activate the healing properties of the blood. BT is photomedicine and has a well-characterized clinical profile. A dozen books and some 400 articles in the German, Russian, and English-language medical literature describe Biophotonic Therapy. Other common names for BT are Ultraviolet Blood Irradiation and Photoluminescence Therapy.
2. In BT’s extracorporeal form, ultraviolet and visible light are used to treat a small amount of blood, which is then reinfused.
3. In BT’s intravenous form, a low-intensity laser (generally at 632.8 nm) shines through a waveguide inside a needle into the blood. BT can also be administered sublingually.
   Continue reading 10 Key Points about Biophotonic Therapy

Humankind needs a low-cost, low-side effects therapy for disseminated infections like HIV and multidrug-resistant TB.  In fact, circumstantial evidence and logic suggest that such a therapy exists.  But, for perverse reasons, it has never been properly tested.  That therapy is Biophotonic Therapy, which can be administered to the blood extracorporeally with various kinds of light or intravenously with a low-intensity laser.  BT has an excellent track record as a treatment of viral disorders ranging from bulbar spinal poliomyelitis to chronic hepatitis.  Invented in the United States in the 1920s, BT has been used extensively in Germany and Russia, but not in any clinical trial against HIV or MDR-TB.

Biophotonic Therapy, however, is not the only approach that calls out for testing against HIV, MDR-TB, and other disseminated infections.  Another candidate is Magnetized Water Therapy.

Biophotonic Therapy uses light in an extracorporeal or intravenous mode to activate the red blood cells, a form of immunity inherited from humankind’s distant oligocellular ancestors. BT has an instructive 80-year history (see below); a range of modalities; well-characterized mechanisms of action; a wide array of indications; several counterindications; well-understood, limited side-effects in certain cases; and a scientific literature that now includes some 400 articles as well as a dozen books. No drug resistance to BT has ever been reported.